| Name: | 8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one |  
| CAS Number:  | 64820-99-1 |  3D/inchi
 |  
| FDA UNII:  | UD7Y63I5X5 |  
| MDL: | MFCD00143627 |  
| XlogP3-AA: | -0.90 (est) |  
| Molecular Weight: | 578.52490000 |  
| Formula: | C27 H30 O14 |  
| BioActivity Summary: | listing |  
| NMR Predictor: | Predict (works with chrome, Edge or firefox) |  
 
Category:natural substances and extractives 
  
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information: 
  
Physical Properties: 
| Assay: |  95.00 to 100.00 
 |  
| Food Chemicals Codex Listed:  | No |  
| Boiling Point: |  898.80 °C. @  760.00 mm Hg (est)
 |  
| Flash Point: |  571.00 °F. TCC (  299.50 °C. ) (est)
 |  
| logP (o/w): |   1.860 (est) |  
| Soluble in: |  
|   | water, 1.1e+004 mg/L @ 25 °C (est) |  
 
  
Organoleptic Properties: 
| Odor and/or flavor descriptions from others (if found). |  
 
  
Cosmetic Information: 
  
Suppliers: 
  
Safety Information: 
|   |  
| Hazards identification |  
|   |  
|  Classification of the substance or mixture |  
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |  
| None found. |  
|  GHS Label elements, including precautionary statements |  
|   |  
| Pictogram |  |  
|   |  
                                                                     
| Hazard statement(s) |  
| None found. |  
| Precautionary statement(s) |  
| None found. |  
| Oral/Parenteral Toxicity:  |  
| 
Not determined
 |  
| Dermal Toxicity:  |  
| 
Not determined
 |  
| Inhalation Toxicity:  |  
| 
Not determined
 |  
 
  
Safety in Use Information: 
| Category:  |  | natural substances and extractives |  
| Recommendation for vitexin 2-O-rhamnoside usage levels up to:  |  |   | not for fragrance use.
 |  
|   |  
| Recommendation for vitexin 2-O-rhamnoside flavor usage levels up to:  |  
|   | not for flavor use.
 |  
 
  
Safety References: 
| EPI System: View |  
| AIDS Citations:Search |  
| Cancer Citations:Search |  
| Toxicology Citations:Search |  
| EPA ACToR:Toxicology Data |  
| EPA Substance Registry Services (SRS):Registry |  
| Laboratory Chemical Safety Summary :5282151 |  
| National Institute of Allergy and Infectious Diseases:Data |  
| WGK Germany:3 |  
| 8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one |  
| Chemidplus:0064820991 |  
 
  
References: 
|   | 8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one |  
| NIST Chemistry WebBook: | Search Inchi |  
| Pubchem (cid): | 5282151 |  
| Pubchem (sid): | 135159752 |  
 
  
Other Information: 
  
Potential Blenders and core components  note 
  
Potential Uses: 
  
Occurrence (nature, food, other): note 
  
Synonyms: 
| (1S)-1,5- | anhydro-2-O-(6-deoxy-a-L-mannopyranosyl)-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol |  |   | apigenin-8-C-glucoside-2'-rhamnoside |  | 8-[(2S,3R,4S,5S,6R)-4,5- | dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one |  |  2-O- | rhamnosylvitexin |  | 2''-O- | rhamnosylvitexin |  |   | vitexin-2''-O-rhamnoside |  
 
  
Articles:
| PubMed:Effects of vitexin-2"-O-rhamnoside and vitexin-4"-O-glucoside on growth and oxidative stress-induced cell apoptosis of human adipose-derived stem cells. |  
| PubMed:Tissue distribution comparison between healthy and fatty liver rats after oral administration of hawthorn leaf extract. |  
| PubMed:Qualitative and quantitative analysis of phenolics in Tetrastigma hemsleyanum and their antioxidant and antiproliferative activities. |  
| PubMed:Nutritional and functional potential of Beta vulgaris cicla and rubra. |  
| PubMed:An enzyme-linked immunosorbent assay for the measurement of plasma flavonoids in mice fed apigenin-C-glycoside. |  
| PubMed:LC determination and pharmacokinetic study of the main phenolic components of Portulaca oleracea L. extract in rat plasma after oral administration. |  
| PubMed:Simultaneous determination of three polyphenols in rat plasma after orally administering hawthorn leaves extract by the HPLC method. |  
| PubMed:HPLC determination of five polyphenols in rat plasma after intravenous administration of hawthorn leaves extract and its application to pharmacokinetic study. |  
| PubMed:Simultaneous determination of vitexin-4''-O-glucoside, vitexin-2''-O-rhamnoside, rutin and vitexin from hawthorn leaves flavonoids in rat plasma by UPLC-ESI-MS/MS. |  
| PubMed:The pharmacokinetics of C-glycosyl flavones of Hawthorn leaf flavonoids in rat after single dose oral administration. |  
| PubMed:[DPPH radical scavenging activities of 31 flavonoids and phenolic acids and 10 extracts of Chinese materia medica]. |  
| PubMed:Screening and structural characterization of alpha-glucosidase inhibitors from hawthorn leaf flavonoids extract by ultrafiltration LC-DAD-MS(n) and SORI-CID FTICR MS. |  
| PubMed:HPLC determination of eight polyphenols in the leaves of Crataegus pinnatifida Bge. var. major. |  
| PubMed:Influence of the extraction mode on the yield of hyperoside, vitexin and vitexin-2''-O-rhamnoside from Crataegus monogyna Jacq. (hawthorn). |  
| PubMed:Assessment of intestinal absorption of vitexin-2''-o-rhamnoside in hawthorn leaves flavonoids in rat using in situ and in vitro absorption models. |  
| PubMed:4'''-Acetylvitexin-2''-O-rhamnoside, isoorientin, orientin, and 8-methoxykaempferol-3-O-glucoside as markers for the differentiation of Crataegus monogyna and Crataegus pentagyna from Crataegus laevigata (Rosaceae). |  
| PubMed:Determination of vitexin-2''-O-rhamnoside in rat plasma by ultra-performance liquid chromatography electrospray ionization tandem mass spectrometry and its application to pharmacokinetic study. |  
| PubMed:Simultaneous determination of vitexin-2"-O-glucoside, vitexin-2"-O-rhamnoside, rutin, and hyperoside in the extract of hawthorn (Crataegus pinnatifida Bge.) leaves by RP-HPLC with ultraviolet photodiode array detection. |  
| PubMed:High-performance liquid chromatographic determination and pharmacokinetic study of vitexin-2''-O-rhamnoside in rat plasma after intravenous administration. |  
| PubMed:Evaluation of the content and stability of the constituents of mother tinctures and tinctures: the case of Crataegus oxyacantha L. and Hieracium pilosella L. |  
| PubMed:Simultaneous determination of vitexin-4''-O-glucoside and vitexin-2''-O-rhamnoside from Hawthorn leaves flavonoids in rat plasma by HPLC method and its application to pharmacokinetic studies. |  
| PubMed:Chemosystematic value of flavonoids from Crataegus x macrocarpa (Rosaceae) with special emphasis on (R)- and (S)-eriodictyol-7-O-glucuronide and luteolin-7-O-glucuronide. |  
| PubMed:[Study on the chemical constituents of the leaves from Crataegus pinnatifida Bge. var. major N. E. Br]. |  
| PubMed:Characterization and biological activity of the main flavonoids from Swiss Chard (Beta vulgaris subspecies cycla). |  
| PubMed:Applied environmental stresses to enhance the levels of polyphenolics in leaves of hawthorn plants. |  
| PubMed:On-line coupling of capillary isotachophoresis and zone electrophoresis for the assay of phenolic compounds in plant extracts. |  
| PubMed:Production of Flavonoids in Cell Cultures of Crataegus monogyna. |  
| PubMed:Antihepatotoxic C-glycosylflavones from the leaves of Allophyllus edulis var. edulis and gracilis. |  
| PubMed:Purification, characterization, and kinetic mechanism of S-adenosyl-L-methionine: vitexin 2"-O-rhamnoside 7-O-methyltransferase of Avena sativa L. |  
 
  
 |